Mexiletine in the Treatment of LQT2, LQT3, and Acquired LQTS: A Meta-Analysis
Background: High mortality in patients with Long QT Syndrome (LQTS) can be reduced with proper treatment. Gene-specific therapy is crucial, as many treatments are not equally effective across different LQTS types. While mexiletine has been established in the treatment of LQT3, its use in other type...
Saved in:
| Main Authors: | Dhiya Ihsan, Mohammad Iqbal, Charlotte Johanna Cool, Chaerul Achmad, Miftah Pramudyo, Hawani Sasmaya Prameswari, Mohammad Rizki Akbar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Indonesian Heart Association
2025-05-01
|
| Series: | Majalah Kardiologi Indonesia |
| Subjects: | |
| Online Access: | https://ijconline.id/index.php/ijc/article/view/1835 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dyskinesia due to mexiletine overdose: a rare presentation
by: Zeynelabidin Öztürk, et al.
Published: (2023-08-01) -
Defining candidate drug characteristics for Long-QT (LQT3) syndrome
by: Aslak Tveito, et al.
Published: (2011-05-01) -
Abnormalities in electrocardiographic ventricular repolarization in patients with dengue virus infection
by: Rosemary Aparecida Furlan-Daniel, et al.
Published: (2019-08-01) -
Theoretical study of interaction between Mexiletine drug and pristine, Si-, Ga- and Al-doped boron nitride nano sheet.
by: Mahla Mosavi
Published: (2022-08-01) -
When HERG-caused LQT2 encounters antisense oligonucleotide: is exon 6 skipping therapy plausible?
by: Zequn Zheng, et al.
Published: (2025-03-01)